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Cholesterol and Bile Acid Metabolism
Are Impaired in Mice Lacking
the Nuclear Oxysterol Receptor LXRa
in mammals. The expression of LXRa is restricted, with
highest levels in the liver (hence, the name liver X recep-
tor) and lower but significant levels in kidney, intestine,
spleen, and adrenals (Apfel et al., 1994; Willyet al.,1995).
LXRb expression is more widespread and has been
Daniel J. Peet,*²# Stephen D. Turley,³
Wenzhen Ma,*² Bethany A. Janowski,²
Jean-Marc A. Lobaccaro,*² Robert E. Hammer,*§
and David J. Mangelsdorf*²‖
*Howard Hughes Medical Institute
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a role in cholesterol metabolism. Cholesterol has twoat Dallas
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steroid hormones or bile acids. Since steroid hormone
synthesis is knownto begoverned by theorphan nuclear
receptor, steroidogenic factor-1 (SF-1) (Parker and Schim-Summary
mer, 1997), we have previously suggested that one plau-
sible candidate pathway for regulation by LXRs is bileWe demonstrate that mice lacking the oxysterol re-
acid synthesis (Janowski et al., 1996). Consistent withceptor, LXRa, lose their ability to respond normally
this notion,we and others proposedthat one likely targetto dietary cholesterol and are unable to tolerate any
of LXR action is cholesterol 7a-hydroxylase (Cyp7a), theamount of cholesterol in excess of that which they
rate-limiting enzyme in the classical bile acid synthesissynthesize de novo. When fed diets containing choles-
pathway (Janowski et al., 1996; Lehmann et al., 1997).terol, LXRa (2/2) mice fail to induce transcription of
Indeed, subsequent experiments have shown that thethe gene encoding cholesterol 7a-hydroxylase (Cyp7a),
Cyp7a promoter contains a functional LXR responsethe rate-limiting enzyme in bile acid synthesis. This
element that can beactivated by RXR/LXR heterodimersdefect is associated with arapid accumulation of large
in an oxysterol- and retinoid-dependent manner (Leh-amounts of cholesterol in the liver thateventually leads
mann et al., 1997; this work; and D. J. M. and B. A. J.,to impaired hepatic function. The regulation of several
unpublished data). The formation of bile acids is one ofother crucial lipid metabolizing genes is also altered
two major pathways for the catabolism and excretionin LXRa (2/2) mice. These results demonstrate the
of cholesterol in mammals (Russell and Setchell, 1992).existence of a physiologically significant feed-forward
Perturbations in this pathway may lead to a variety ofregulatory pathway for sterol metabolism and estab-
disorders, including cholesterol gallstones, atheroscle-lish the role of LXRa as the major sensor of dietary
rosis, and some lipid storage diseases (Akiyoshi et al.,cholesterol.
1986; Turley and Dietschy, 1988; Carey and Duane,
1994). Together, these observations have raised the in-Introduction
teresting possibility that LXRs may function as important
transcriptional control points in bile acid metabolism.
Nuclear receptors are ligand-activated transcription fac-
To address further the physiological role of LXRs and
tors that govern aspects of every major developmental
their potential to regulate cholesterol catabolism, we
and metabolic pathway (reviewed in Kastner et al., 1995;
characterized the phenotype of mice harboring targeted
Mangelsdorf et al., 1995). The LXRs were first identified
null mutations in each of the LXR genes. In this paper,
as orphan members of the nuclear receptor superfamily we report that mice lacking the Lxra gene lose the ca-
whose ligands and functions are unknown (Willy and
pacity to regulate the catabolism of dietary cholesterol
Mangelsdorf, 1998). Recently, the LXRs were shown to
in the liver. The consequence of this loss is a rapid
be activated by a specific class of naturally occurring,
accumulation of hepatic cholesteryl esters that eventu-
oxidized derivatives of cholesterol, including 22(R)- ally leads to liver failure. As predicted, LXRa null mice
hydroxycholesterol, 24(S)-hydroxycholesterol, and 24, aberrantly regulate Cyp7a gene expression and have a
25(S)-epoxycholesterol (Janowski et al., 1996; Lehmann substantially altered bile acid metabolism. In addition,
et al., 1997). These oxysterols are concentrated in tis- several crucial regulatory proteins and enzymes in-
sues where cholesterol metabolism and LXR expression volved in sterol and fatty acid synthesis are abnormally
are high, such as liver, brain, and placenta (Lavy et al., expressed, suggesting LXRa has a wide ranging effect
1977; Spencer et al., 1985; LuÈ tjohann et al., 1996). LXRs on hepatic lipid metabolism. Taken together, our results
function as heterodimers with the retinoid X receptors show that LXRa functions as an essential regulatory
(RXRs), and thus, the RXR/LXR complex can be acti- component of cholesterol homeostasis and that no
vated by both RXR ligands (i.e., rexinoids) and oxyster- other mechanisms exist to compensate for its loss.
ols (Teboul et al., 1995; Willy et al., 1995; Janowski et
al., 1996). Two LXR proteins (a and b) are known to exist Results
Targeted Disruption of the Lxra Gene‖ To whom correspondence should be addressed.
Figure 1A shows the strategy used to knock out the# Present address: Department of Biochemistry, University of Ade-
laide, Adelaide SA 5005, Australia. Lxra gene. The mouse Lxra gene includes nine exons
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Figure 1. Targeted Disruption of the Mouse Lxra Gene
(A) Targeting strategy for LXRa. A partial map of the genomic locus surrounding the Lxra locus is shown. The numbered open boxes represent
exons, with exon 3 containing the DNA-binding domain (designated D). Homologous recombination resulted in the replacement of exons 3±6
with the neo resistance gene. Restriction enzyme sites are indicated: RI, EcoRI; H3, HindIII; Ap, ApaI; Nc, NcoI. The neo and herpes simplex
thymidine kinase (TK) genes are indicated with arrows.
(B) Northern blot of liver mRNA. Liver mRNA was hybridized using the full-length mouse Lxra cDNA probe.
that encompass the translated portion of the gene. Ex- deleterious effects (Breslow, 1996), one hypothesis we
wished to explore was whether LXRa null mice had aons 1 and 2 encode the amino-terminal portion of the
defect in their ability to respond to dietary cholesterol.receptor (A/B regions), exon 3 encodes all of the DNA-
To test this idea, 2±3 month old, gender-matched LXRabinding domain (C region), and exons 4±9 encode the
wild-type and null mice were characterized after beinghinge and ligand-binding domains (D and E regions). A
reared on diets containing different cholesterol concen-targeting construct was prepared by inserting a PGK-
trations for 0, 7, 30, and 90 days. Analysis of LXRaneo cassette between an ApaI site at the beginning of
(2/2) animals fed a standard laboratory rodent chowexon 3 and an NcoI site in the intron between exons 6
indicated these mice appeared identical to their wild-and 7. Homologous recombination of this construct in
type littermates as determined by morphological andSM-1 ES cells replaced exons 3±6 encoding the DNA-
histological studies (see below). In retrospect, the lackbinding and ligand-binding domains of LXRa (amino
of a gross phenotype on this diet in the mutant miceacids 86±327). Two ES cell clones were chosen for gen-
is perhaps not surprising, since standard rodent choweration of chimeric, heterozygous (LXRa (1/2)) and ho-
contains relatively little cholesterol (#0.02% w/w). Onmozygous (LXRa (2/2)) mice. Mutant mice were viable
this diet, the cholesterol requirement of these animalsand fertile, and they externally appeared normal when
is achieved primarily through de novo biosynthesisreared under normal laboratory conditions on standard
(Osono et al., 1995).rodent chow. Under these conditions, heterozygous and
We next tested the effect of a diet rich in cholesterolhomozygous animals lived normal lifespans and bred
(chow supplemented with 2% cholesterol). On a perwith predicted Mendelian distributions. Analysis of liver
diem basis, the intake of cholesterol on this diet is ap-mRNA from these mice revealed that heterozygotes re-
proximately 20±30 times above the amount an averagetain significant levels of LXRa transcripts (z50% of wild
animal synthesizes to maintain homeostasis when itstype), while no wild-type transcripts are detected in ho-
dietary needs are not being met (Osono et al., 1995). Inmozygous mice (Figure 1B). In addition, no LXRa protein
contrast to wild-type animals, which can sustain this
was detected in homozygotes by immunoblot analysis
cholesterol-rich diet indefinitely without deleterious ef-
using antibodies specific for the hinge region of LXRa
fects, there were dramatic morphological, histological,
(data not shown). We conclude that this disruption re- and chemical changes in the livers of LXRa null mice
sults in mice that are null for LXRa. fed the same diet (Figures 2 and 3). Within 7 days of
beginning the 2% cholesterol diet and chronically wors-
Hepatomegaly and Cholesterol Accumulation ening over a 90-day period, there was a prominent color
in LXRa Null Mice and size change in the LXRa (2/2) versus wild-type
Previously, we and others have shown that LXRs are livers (Figures 2A and 3A). Histological examination of
activated by a specific group of monooxidized metabo- these livers demonstrated the presence of a time-depen-
lites of cholesterol, including 22(R)-hydroxycholesterol, dent increase in the number and size of intracellular
24(S)-hydroxycholesterol, and 24,25(S)-epoxycholes- vacuoles, characteristic of lipid deposits (Figure 2B). Oil
terol (Janowski et al., 1996; Lehmann et al., 1997). The red O staining of liver sections verified the deposition
fact that these metabolites are naturally occurring and of increasing quantities of lipid by 7 and 30 days (Figure
are elevated in tissues where cholesterol metabolism is 2C). After 90 days, the morphology of the LXRa (2/2)
high (e.g., the liver) led to the prediction that LXRs may livers had been substantially altered, and there was dis-
have a role in the regulation of cholesterol metabolism. tinct evidence of increased hematopoietic foci, macro-
Since wild-type murine species have an extraordinary phage infiltration, and progressive hepatocellular de-
generation (Figures 2A±2C). Chemical analysis of thesecapacity to ingest large quantities of cholesterol without
Cholesterol Metabolism in LXRa (2/2) Mice
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livers showed that, consistent with the distinct color Analysis of the plasma from the animals used in the
change, all of the accumulated lipid is in the form of above dietary studies confirms and extends the conclu-
cholesterol (Figure 3B, see also Figure 5A below), 75% sion that LXRa null animals have a crucial defect in
of which is esterified (data not shown). Remarkably, the hepatic metabolism of dietary cholesterol (Table 1).
LXRa null animals exhibited a 15- to 20-fold increase in Plasma cholesterol levels rose significantly (.200%)
hepatic cholesterol within just 7 days of feeding the over the course of the 90-day, high-cholesterol diet in
cholesterol-rich diet (Figure 3B). Both liver mass and LXRa (2/2) mice, while wild-type mice characteristically
cholesterol concentration continued to increase with showed no change. There was also a dramatic increase
time, and by 90 days the LXRa (2/2) livers had doubled in the levels of alanine and aspartate amino transferases
in mass (Figures 3A and 3B) and were in the advanced (26- and 7-fold, respectively, within 30 days) in the serum
stages of failure (see below). Consistent with the known of the LXRa (2/2), but not wild-type animals. These
ability of wild-type animals to adapt quickly to choles- enzymes are predominantly expressed in the liver, and
terol-rich diets, the livers of LXRa (1/1) animals main- the large increase in their levels in serum is indicative
tained essentially normal appearance and function. In of hepatocyte injury and necrosis and is consistent with
these animals, there were no significant changes in liver the results of the histological studies. By 90 days, the
histology or size, and only nominal increases in hepatic LXRa (2/2) livers deteriorated to the point where they
cholesterol were detected. Interestingly, there was an have lost much of their normal cell structure (Figure 2C),
increase in hepatic triglyceride levels in wild type, but and this change was reflected by the observed decrease
not LXRa null mice (Figure 3C). The elevated hepatic (between 30 and 90 days) in the levels of amino trans-
triglyceride level seen in the wild-type mice explains the ferases still present in the serum of these animals (Table
slight pigment change in the livers of these animals 1). Commensurate with impaired liver function, LXRa
(Figure 2A), even though their cholesterol levels re- null mice exhibited a time-dependent decrease in serum
mained low. glucose to half the normal level of their wild-type lit-
To confirm the dietary dependence of the defect seen termates when fed the high-cholesterol diet. Although
in LXRa (2/2) mice, a second group of wild-type and several other parameters in the plasma, including tri-
homozygous animals was analyzed after 7 and 22 days glycerides, total protein, albumin, creatinine, and elec-
on an intermediate cholesterol diet (chow supplemented trolytes appeared normal (Table 1 and data not shown),
with 0.2% cholesterol). On this diet, the average animal
these results demonstrate that significant liver damage
consumes an amount of cholesterol per day that is ap-
has occurred by 90 days and suggest that extension of
proximately twice what it needs to maintain normal ho-
this diet will ultimately result in complete liver failure.
meostasis. As shown in Figure 3D, LXRa (2/2) mice
A characteristic of murine species is their ability to
accumulated hepatic cholesterol to levels 3- and 10-
regulate intermediate and low-density lipoprotein (IDL/
fold higher than wild-type mice when fed a 0.2% choles-
LDL) cholesterol in serum tightly even under prolongedterol diet for 7 and 22 days, respectively. A comparison
conditions of elevated cholesterol intake. Since the dataof Figures 3B and 3D shows that the defect in LXRa
from Table 1 revealed an increase in plasma cholesterol(2/2) mice causes a near linear accumulation of hepatic
in the LXRa null mice, a plasma lipoprotein profile wascholesterol, regardless of whether the diet contains
generated from wild-type and homozygous mice fed0.2% or 2% cholesterol. These results demonstrate that,
standard or 2% cholesterol chow diets for 30 days. Asin the absence of LXRa, mice are unable to tolerate any
predicted, wild-type animals were resistant to large in-dietary cholesterol inexcess of what they can synthesize
creases in dietary cholesterol and maintained very lowde novo.
circulating levels of IDL/LDL cholesterol (Figures 4A andSimilar dietary studies were performed using hetero-
4B). However, LXRa (2/2) animals produced an z5-foldzygous mice, which express approximately half of the
increase in IDL/LDL cholesterol and only minimal changeslevels of LXRa (Figure 1B). These mice displayed an
in HDL when compared to LXRa (1/1) animals fed theintermediate phenotype, accumulating hepatic choles-
2% cholesterol±supplemented diet (Figure 4B).terol concentrations to levels between those observed
for LXRa (1/1) and (2/2) mice (Figure 3E). These results
Cholesterol and Bile Acid Metabolism Defectsindicate that expression levels of LXRa are crucial for
in LXRa Null Micea complete response.
The phenotype described above provides convincingSignificantly, there were no changes in the body
evidence that one of the roles of LXRa is to regulateweights of either LXRa (2/2) or (1/1) mice, irrespective
dietary cholesterol metabolism in the liver. Since theof the type or length of the diet. However, there was a
primary pathway for catabolic elimination of cholesterolnoticeable decrease in the amount of white adipose
is through bile acid metabolism, we next examined thetissue in LXRa (2/2) mice after 90 days on the 2%
response of several important components in this path-cholesterol diet, which likely compensated for the net
way. An 8-day dietary study similar to the one describedincrease in liver mass (data not shown). Morphological
above was performed on 3-month-old male mice, com-and histological examinations of several other tissues
paring wild-type and LXRa (2/2) animals fed standardwhere LXRa is expressed, including kidney, small intes-
or 2% cholesterol±supplemented chow. The animals intine, spleen, and adrenal, are ongoing, but preliminary
this group were analyzed for rates of fecal bile acidresults have revealed no obvious abnormalities in these
excretion, and bile acid pool size and composition (Fig-tissues thus far (data not shown). To date, no gender-
ure 5). Similar to the results obtained above, LXRa (2/2)specific phenotypic differences have been observed in
animals manifest a 16-fold increase in hepatic choles-LXRa knockout mice, although female mice tend to have
higher basal and diet-induced cholesterol levels. terol when fed a 2% cholesterol chow diet (Figure 5A).
Figure 2. Morphology and Histology of Livers from LXRa Knockout versus Wild-Type Mice on High-Cholesterol Diets
(A) Gross morphology of livers from female LXRa null (2/2) and wild-type (1/1) mice fed chow supplemented with 2% cholesterol for 0, 7,
30, or 90 days. The development of fatty livers in the LXRa (2/2) mice is evident after 7 days on the high-cholesterol diet. Bar 5 10 mm. Liver
sections from (A) were prepared for histology and stained with hematoxylin and eosin (B) or oil red O (C). The unstained vacuoles visible in
the hematoxylin- and eosin-stained sections of the LXRa (2/2) mice on the high-cholesterol diet stain positive (red color) for lipids with oil
red O. Bars 5 10 mm.
Cholesterol Metabolism in LXRa (2/2) Mice
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Figure 3. Liver Chemistries from LXRa Knock-
out versus Wild-Type Mice on High or Inter-
mediate Cholesterol Diets
(A) Liver mass relative to total body mass of
LXRa (2/2) and (1/1) female mice fed chow
supplemented with 2% cholesterol for 0, 7,
30, or 90 days. Measurements of hepatic cho-
lesterol (B) and triglycerides (C) quantitated
enzymatically from extracts of the livers in
(A). The animals used in this study are the
same as in Figure 2. (D) Hepatic cholesterol
concentrationsof LXRa (2/2) and (1/1) male
mice fed chow supplemented with 0.2% cho-
lesterol for 0, 7, or 22 days. (E) Hepatic cho-
lesterol concentrations of LXRa (1/1), (1/2),
and (2/2) female mice fed chow supple-
mented with 2.0% cholesterol for 0 or 7 days.
All values are expressed as mean 6 SEM, n 5
5. Significant differences compared to wild-
type mice on the same diet: *, P , 0.05; **,
P , 0.01; ***, P , 0.001.
Within 8 days, the concentration of hepatic cholesterol (Cohen et al., 1977; Uchida et al., 1980). As shown in
Figure 5D, wild-type animals respond to increased di-rose in LXRa null mice from its normal value of 2.46 6
0.05 mg/g to 40.09 6 0.82 mg/g tissue, whereas hepatic etary cholesterol by substantially lowering this ratio
(from 1.34 6 0.08 to 0.88 6 0.05). In contrast, LXRacholesterol in wild-type mice increased nominally from
2.21 6 0.03 mg/g to 5.03 6 0.19 mg/g tissue. Interest- (2/2) mice have a significantly higher basal ratio (2.03 6
0.23), which is completely unresponsive to increasedingly, even onthe low-cholesterol diet there was a statis-
tically significant difference (P , 0.001) between the cholesterol (2.21 6 0.57). The above results are consis-
tent with the notion that LXRa (2/2) mice lack a choles-hepatic cholesterol concentration in LXRa (1/1) and
(2/2) mice (2.21 6 0.03 and 2.46 6 0.05 mg/g, respec- terol-sensing mechanism that governs the clearance of
excess cholesterol through bile acid synthesis.tively; Figure 5A, inset). These phenotypes were inde-
pendent of gender (compare Figures 3B [female] to 5A
[males]). Regulation of Cyp7a by LXRa
The ability of wild-type animals to maintain a relatively The rate-limiting step in the classical bile acid synthesis
low hepatic cholesterol concentration when cholesterol pathway utilizes the liver-specific enzyme cholesterol
intake is high is largely due to the compensatory in- 7a-hydroxylase (Cyp7a), which converts cholesterol into
crease in bile acid synthesis (Figures 5B and 5C). The 7a-hydroxycholesterol (Russell and Setchell, 1992). In
123% increase in fecal bile acid excretion (Figure 5B)
and 36% increase in bile acid pool size (Figure 5C) were
substantial and expected, based on previous studies
Table 1. Plasma Analysis of Wild Type and LXRa (2/2) after 2%
showing that bile acid metabolism is responsible for Cholesterol Dietsa
metabolic clearance of dietary cholesterol (Carey and
0 7 30 90Duane, 1994; S. D. T., M. Schwarz, D. K. Spady, and
Test Genotype Days Days Days DaysJ. M. Dietschy, unpublished data). In marked contrast,
Cholesterol 1/1 84 82 105 82the bile acid pool size of the LXRa (2/2) mice was
(mg/dL, 6 ,3.5%) 2/2 72 127 162 145significantly lower than wild-type mice and did not
Alanine transaminase 1/1 17 19 13 15change when the animals were fed the cholesterol-rich
(U/L, 6 ,5.5%) 2/2 12 98 314 188diet (Figure 5C). In addition, bile acid excretion in the
LXRa (2/2) mice increased less than half the amount Aspartate transaminase 1/1 39 44 41 45
(U/L, 6 7%) 2/2 44 160 303 197it did in wild-type animals (Figure 5B). Since ordinarily
bile acid excretion reflects bile acid synthesis, these Glucose 1/1 231 247 200 219
results imply that LXRa null mice have a decreased (m/dL, 6 ,3%) 2/2 178 195 109 121
ability to upregulate bile acid synthesis. Triglycerides 1/1 52 38 39 43
An analysis of bile acid pool composition revealed a (mg/dL, 6 ,5%) 2/2 46 35 29 31
striking difference in this parameter as well. Over 95% Total protein 1/1 4.7 ND 4.4 4.4
of the murine biliary bile acid pool is composed of cholic (g/dL, 6 ,4%) 2/2 4.6 4.7 5.4 4.7
and muricholic acids (Akiyoshi et al., 1986). The ratio of
Albumin 1/1 1.7 1.5 1.5 1.5
cholic acid to muricholic acid is tightly regulated and (g/dL, 6 ,3%) 2/2 1.6 1.6 1.6 1.4
has a significant effect on the animal's ability to absorb
a All measurements performed on plasma pooled from groups of fivecholesterol in the intestine; the higher the ratio, the more
female mice.
cholesterol that is potentially capable of being absorbed
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Figure 4. Plasma Lipoprotein Profiles of LXRa
Knockout versus Wild-Type Mice
Plasma lipoprotein profiles of LXRa (2/2) and
(1/1) female mice fed chow alone (A) or sup-
plemented with 2% cholesterol (B) for 30
days. Fasting plasma samples from 5 mice
were pooled, fractionated by FPLC, and total
cholesterol in each fraction was quantitated
as described in the Experimental Procedures.
Total plasma cholesterol concentrations are
presented in Table 1. The animals used in this
study are the same as in Figure 2.
murine species, this enzyme is transcriptionally regu- level of hepatic LXRb in LXRa (2/2) mice. Furthermore,
cotransfection studies with LXRaand b expression plas-lated by dietary cholesterol (Rudling, 1992), and we and
others have shown that the Cyp7a promoter contains a mids demonstrate that the LXRE found in the Cyp7a
promoter is a substantially stronger response elementfunctional LXR response element (i.e., LXRE) (Lehmann
et al., 1997; see also below). In addition to Cyp7a, a for LXRa than it is for LXRb (Figure 6C). These results
corroborate the previous findings of Lehmann and co-second enzyme called oxysterol 7a-hydroxylase (Cyp7b)
exists as part of an alternative bile acid synthesis path- workers, showing that LXRa has a substantially higher
affinity than LXRb for binding to the Cyp7a LXRE (Leh-way, which is not transcriptionally regulated by choles-
terol (Schwarz et al., 1997). Therefore, it was of interest mann et al., 1997). Taken together with the striking phe-
notype of LXRa (2/2) mice, we conclude that LXRa andto characterize the response of these genes in the LXRa
(2/2) mice. As expected, Cyp7a mRNA was up-regu- b can differentially regulate gene expression and, thus,
may have nonoverlapping roles.lated (5.9-fold) in wild-type mice fed a high-cholesterol
diet for 7 days (Figure 6A). However, there was no cho-
lesterol-induced up-regulation of Cyp7a in LXRa (2/2) Impaired Expression of Hepatic Genes Involved
in Multiple Lipid Pathwaysmice, consistent with the notion that this gene is a direct
target of LXRa action. In contrast to Cyp7a, there were In addition to the genes involved in bile acid metabolism,
the expression of 18 other genes involved in cholesterolno differences in expression of Cyp7b in either LXR
(1/1) or (2/2) mice (Figure 6A). and fatty acid metabolism were investigated by Northern
blot analysis (Figure 7). End product repression of cho-In addition to normally expressing LXRa, the liver also
expresses the closely related receptor, LXRb (Figure lesterol biosynthesis is a well-studied pathway that is
controlled primarily by the transcription factor SREBP-26B). Since both of these receptors have similar ligand
specificities (Janowski et al., 1996; Lehmann et al., (Brown and Goldstein, 1997). As expected, the liver
mRNA levels of SREBP-2, as well as the cholesterogenic1997), we wished to address why LXRb cannot rescue
the bile acid phenotype in LXRa (2/2) mice. As shown enzymes,hydroxymethyl glutaryl-coenzyme A (HMG-CoA)
synthase and reductase, farnesyl diphosphate (FPP)in Figure 6B, the expression of the Lxra and b genes is
not regulated by dietary cholesterol, indicating that the synthase, and squalene synthase were down-regulated
in response to cholesterol in both LXRa (1/1) and (2/2)LXRs are not likely to be autoregulated in the liver. More
importantly, there was no compensatory increase in the animals (Figure 7). Surprisingly, however, there was a
Figure 5. Bile Acid Pool Size and Excretion in LXRa Knockout versus Wild-Type Mice
(A) Hepatic cholesterol concentrations from LXRa (2/2) and (1/1) male mice fed chow alone or supplemented with 2% cholesterol for 8
days. Inset, enlargement of hepatic cholesterol concentrations of LXRa (2/2) and (1/1) mice on a chow-only diet showing a statistically
significant difference (2.21 6 0.033 versus 2.46 6 0.050 mg/g liver, P , 0.001). (B) Fecal bile acid excretion was determined from extraction
and analysis of stool samples collected from the mice in (A) over the final 72 hr period of the 8 day diet. (C) Bile acid pool size from gallbladder,
surrounding liver, and small intestine taken from mice in (A). (D) Bile acid composition of pool in (C). CA, cholic acid; MCA, muricholic acid.
All values are expressed as mean 6 SEM, n 5 10. Significant differences compared to same genotype on chow diet: *, P , 0.05; ***, P ,
0.001. Significant differences compared to wild-type mice on chow diet: (*), P , 0.05; (***), P , 0.001.
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Figure 6. Transcriptional Regulation of Sterol 7a-Hydroxylases by LXRs
Northern blots of liver mRNA isolated from LXRa (2/2) and (1/1) male mice fed chow alone or chow supplemented with 2% cholesterol for
7 days, and probed for (A) cholesterol 7a-hydroxylase (Cyp7a) and oxysterol 7a-hydroxylase (Cyp7b), or (B) for LXRa and LXRb. mRNA was
isolated from five mice in each group and pooled prior to Northern blotting. Quantitation of bands relative to b-actin controls was performed
as described in the Experimental Procedures. Foldchanges in Cyp7a mRNA are compared to (1/1) mice on the chow diet and are representative
of two or more independent experiments. Similar results were observed with female mice on the same diet. (C) LXRa and b differentially
regulate transcription through the Cyp7a LXRE. Mouse Hepa1-6 cells were cotransfected with the luciferase reporter plasmid TK-CYP7A-
LXREx3-LUC together with the expression plasmids for mLXRa or mLXRb, and incubated with various concentrations of 24(S),25-epoxycholes-
terol. RLU, relative light units.
significant increase in the expression of these genes in further synthesis through a well-documented pathway
involving the transcription factors SREBP-1 and SREBP-2the LXRa (2/2), but not wild-type, animals fed a low-
(Brown and Goldstein, 1997). When cholesterol is in-cholesterol diet. At present, the consequence of the
cluded in the diet at levels surpassing the biosyntheticaltered up-regulation of these genes is not fully under-
rate, a feed-forward pathway is activated that increasesstood and will require further study; however, the lack
liver cholesterol catabolism and bile acid mobilizationof a severe phenotype under low dietary cholesterol
(Russell and Setchell, 1992). The ability to greatly upreg-conditions suggests this misregulation may not be dele-
ulate this feed-forward pathway explains why mice fedterious. Furthermore, no differences were seen in the
excessive amounts of cholesterol are able to maintainregulation of SREBP cleavage activating protein (SCAP),
relatively normal lipid physiology. However, the mecha-sterol carrier protein, LDL receptor, HDL receptor (SR-
nism by which this pathway is regulated has remainedB1), or apolipoprotein gene expression in the LXRa null
unknown. Our results demonstrate that LXRa is a keymice (Figure 7).
component of this regulation. By binding to the oxyste-In contrast to the up-regulation of genes involved in
rols that exist in liver when there is a surplus of choles-cholesterol biosynthesis, three genes involved in fatty
terol (Janowski et al., 1996; Lehmann et al., 1997), weacid metabolism, SREBP-1, stearoyl CoA desaturase-1,
propose that LXRa acts as a cholesterol sensor andand fatty acid synthase, were markedly down-regulated
upregulates expression of various components of cho-in LXRa (2/2) mice on the low-cholesterol diet (Figure
lesterol catabolism. In keeping with this model, we have7). Again, the consequence of the altered expression of
shown that the absence of LXRa results in a block inthese genes on this diet does not appear to be deleteri-
the catabolic pathway, which in turn leads to the rapidous, but further study will be required to determine if
accumulation of hepatic cholesterol. As the sensor,there are other metabolic defects in these mice under
LXRa must be exquisitely responsive, since even a slightother dietary conditions (e.g., low or high fatty acid±
increase in dietary cholesterol results in a pronouncedsupplemented diets). The expression of several other
accumulation of hepatic sterols in LXRa (2/2) animalsgenes, including the three peroxisome proliferator acti-
(Figure 3D). Furthermore, we have shown that a major
vated receptors (PPARs) and acetyl CoA carboxylase
mechanism by which the presence of LXRa keeps the
were unchanged in the mutant versus wild-type mice.
level of dietary cholesterol in check is by positively regu-
lating transcription of the rate-limiting enzyme in bile
Discussion acid synthesis, cholesterol 7a-hydroxylase (Cyp7a). This
regulatory paradigm is the antithesis of the feed-back
Model of the Regulation of Cholesterol Homeostasis control mechanism that transcriptionally represses the
In this paper, the in vivo role of LXRa was investigated rate-limiting enzyme in cholesterol synthesis (Brown and
by generating knockout mice. The results from this in- Goldstein, 1997) and provides an elegant symmetry to
vestigation support a model in which LXRa plays a cru- the regulation of cholesterol homeostasis (Figure 8).
cial role in regulating the catabolism of dietary choles-
terol in the liver (Figure 8). It is well established that LXRa Regulation of Bile Acid Metabolism
cholesterol homeostasis is maintained in normalanimals In support of the notion that a primary target of LXRa
through two regulated pathways: de novo synthesis and regulation is bile acid metabolism, we have demon-
catabolism. Biosynthesis is governed by the accumula- strated that LXRa knockout animals have marked differ-
ences in bile acid excretion, pool size, and composition.tion of sterols in the liver, which feed back and inhibit
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Figure 7. Northern Blot Analysis of Various Lipid Regulating Genes in LXRa Knockout versus Wild-Type Mice
Northern blots of liver mRNA isolated from LXRa (2/2) and (1/1) male mice fed chow alone or supplemented with 2% cholesterol for 7 days.
The source of mRNA was the same as in Figure 6. Quantitation of bands relative to b-actin controls was performed as described in the
Experimental Procedures. Fold changes in mRNA are compared to (1/1) mice on the chow diet and are representative of two or more
independent experiments. Similar results were observed with female mice on the same diet.
Of particular interest are the differences in bile acid Significantly, although the hepatic cholesterol level is
higher than normal, it does not increase further as longpool composition, since this parameter not only reflects
cholesterol catabolism, but also has an effect on choles- as theseanimals maintain their dietary cholesterol intake
below the maximum amount they are able to synthesize.terol absorption from the diet (Cohen et al., 1977; Uchida
et al., 1980). The substantial increase in the ratio of However, once the dietary intake exceeds the biosyn-
thetic rate, hepatic cholesterol accumulation increasescholic acid to muricholic acid seen in the LXRa (2/2)
mice suggests that these animals may potentially ab- in an almost linear fashion (Figures 3B and 3D). Taken
together, these phenotypes demonstrate that the up-sorb more dietary cholesterol. Thus, in addition to regu-
lating cholesterol catabolism and excretion, LXRa may regulation of Cyp7a enzyme activity is crucial for the
metabolic clearance of dietary cholesterol, but addi-also govern cholesterol uptake. It is also of interest that
LXRa (2/2) mice maintain a statistically higher basal tional LXRa targets may also exist. Consistent with this
notion, in ongoing experiments we have shown that evenconcentration of hepatic cholesterol, even when fed a
low (0.02%) cholesterol diet (Figures 3B and 5A, inset). when all Cyp7a activity is inhibited in wild-type animals
by feeding a high-cholesterol diet artificially supple-
mented with cholic acid (Jelinek et al., 1990; Shefer et
al., 1991, Schwarz et al., 1997), these animals exhibit a
similar but not identical phenotype to that seen in LXRa
null mice fed the same diet without cholic acid.
LXRa Regulation of Sterol and Fatty
Acid Metabolism
The transcriptional regulation of several genes involved
in both sterol and fatty acid synthesis were also shown
to be altered in LXRa (2/2) mice (Figure 7). Under condi-
tions of low dietary cholesterol, the levels of all the major
cholesterogenic enzyme mRNAs were increased, in-
Figure 8. Model for the Regulation of Cholesterol Homeostasis
cluding that for the rate-limiting enzyme HMG CoA re-
Cholesterol metabolism is governed by two mechanisms: feed-back ductase. Concordant with these increases, mRNA levels
repression of biosynthesis through the inhibition of the transcription
of SREBP-2, a known transcriptional regulator of thesefactor SREBP and feed-forward induction of catabolism by ligand-
genes, were also elevated. Although previous studiesdependent activation of the oxysterol receptor LXRa. See text for
details. have shown that a clear relationship exists between the
Cholesterol Metabolism in LXRa (2/2) Mice
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up-regulation of these genes and cholesterol synthesis predicted, these two metabolic pathways have similar
intermediary enzymatic steps that involve hydroxylationin normal animals (Brown and Goldstein, 1997), a num-
ber of the products of these genes are also known to of the side chain and ring structures of cholesterol. Like-
wise, it is perhaps not surprising to learn that both path-be posttranslationally regulated. In ongoing experiments
with LXRa null animals, we have notedthat the increased ways are transcriptionally regulated by nuclear recep-
tors (Figure 8). Similar to LXRa's regulation of bile acidexpression of these enzymes does not result in the pre-
dicted increase in hepatic cholesterol synthesis. Al- metabolism, the orphan nuclear receptor steroidogenic
factor-1 (SF-1) has been shown to regulate several stepsthough preliminary, these results suggest the existence
of a separate regulatory pathway for these enzymes that in the steroidogenic pathway, including expression of
the rate-limiting cholesterol side chain cleavage en-uncouples them from cholesterol biosynthesis. Future
studies will be directed at understanding the conse- zyme, Cyp11a (Parker and Schimmer, 1997). The knock-
out of the gene encoding SF-1 results in complete adre-quence of this aberrant up-regulation, including whether
or not an alternate lipidbiosynthetic pathway is involved, nal and gonadal agenesis, confirming the role of this
nuclear receptor in steroidogenesis (Luo et al., 1994).perhaps generating an LXRa ligand. On this point, we
note that one of the highest affinity ligands for LXRa is Moreover, SF-1 has also recently been shown to be
activated by oxysterols (Lala et al., 1997). Interestingly,the liver-specific sterol 24(S),25-epoxycholesterol (Fig-
ure 6; B. A. J., S. A. Jones, S. A. Kliewer, and D. J. M., the SF-1 activators exhibit a different rank order of spec-
ificity than LXR ligands (Lala et al., 1997). These resultsunpublished data), which is believed to be synthesized
directly from squalene in a shunt pathway that bypasses suggest that, like the receptors for steroids, retinoids,
and prostanoids, there exists a family of receptors forthe last several steps in the synthesis of cholesterol
(Spencer, 1994). oxysterols whose function is to regulate important meta-
bolic pathways. At least one other oxysterol receptor,In contrast to cholesterogenic genes, mRNA for genes
involved in fatty acid synthesis were down-regulated in LXRb, is already known to exist, and the elucidation of
its biological role is a future goal.LXRa knockout mice. The most dramatic decrease was
seen with stearoyl CoA desaturase-1, the enzyme re-
quired for synthesis of D9-unsaturated fatty acids that Conclusions
are essential constituents of all membrane phospho- In conclusion, the characterization of the LXRa knockout
lipids and triglycerides. These enzymes are known to mouse provides unequivocal evidence that LXRa sub-
be transcriptionally regulated by SREBP-1 (also called serves a key role in cholesterol homeostasis. The finding
ADD1), which was originally characterized for its effects that LXRa is a crucial checkpoint in this process may
on adipocyte differentiation (Tontonoz et al., 1993) and have broad implications for its potential use as a target
is believed to have more of a role in fatty acid metabo- in human disease. For example, genetic screening for
lism. In LXRa (2/2) mice, the levels of both the mRNA LXRa mutations may prove useful in identifying patient
(Figure 7) and active nuclear form (data not shown) of cohorts with inherited defects in cholesterol metabolism
SREBP-1 are down-regulated, implying that LXRa may (especially of dietary origin). Likewise, the availability of
govern synthesis of essential fatty acid components by the LXRa knockout mouse as an animal model and the
directly controlling SREBP-1 expression. This pheno- future development of nonsteroidal LXRa agonists should
type is consistent with that of transgenic mice express- provide useful tools for exploring the utility of LXRa as
ing a constitutively active form of SREBP-1, in which a pharmaceutical target.
fatty acid synthesizing enzymes are dramatically ele-
vated, resulting in a fatty liver phenotype (Shimano et Experimental Procedures
al., 1996). Dietary studies varying the fat intake of these
Construction of the LXRa Targeting Vectoranimals are under way to understand further the role of
Mouse LXRa genomic clones were obtained by screening a 129SvLXRa in this pathway.
l genomic library using the 1.4 kb full-length cDNA of human LXRaThe loss of LXRa leads to one other noteworthy phe-
(Willy et al., 1995). The targeting vector was constructed using anotype: an increase inplasma LDL cholesterol. This phe-
neo-TK template plasmid containing a neomycin and two tandem
notype is rather unique, since it is well known that mice herpes simplex virus thymidine kinase cassettes (Rosahl et al.,
are highly resistant to any changes in circulating LDL 1993). This vector was designed to replace exons 3±6 by homolo-
gous recombination, which contain the complete DNA-binding do-unless mutations are introduced that alter expression
main and majority of the ligand-binding domain of LXRa (aminoof apolipoproteins or the LDL receptor (Breslow, 1996).
acids 86±327). A short arm was generated by blunt end insertingWe observed no statistically relevant LXRa-dependent
the 1.9 kb EcoRI-ApaI fragment containing exons 1 and 2 into thechanges in the mRNA levels of apolipoproteins A and
unique BamHI site 59 of the neo cassette, and the longer arm by
E (Figure 7), apolipoprotein B (data not shown), LDL blunt end inserting the 4.0 kb NcoI fragment containing exons 7±9
receptor, or HDL receptor, yet there was a significant into the unique XhoI site located between the neo and TK cassettes
increase in LDL cholesterol plasma levels after feeding (Figure 1). The targeting vector was linearized at a unique SalI site
prior to electroporation.a cholesterol-rich diet. These findings suggest the LXRa
null mouse may be a useful animal model for the further
Generation of LXRa Null Micestudy of cholesterol homeostatic diseases such as ath-
Ablation of the mouse Lxra gene locus was accomplished accordingerosclerosis.
to previously described methods (Ishibashi et al., 1993; Rosahl et
al., 1993). SM-1 mouse ES cells were grown on irradiated STO feeder
A Family of Oxysterol Receptors cells. Approximately 5 3 107 cells were electroporated with 1 mg/ml
In addition to bile acid synthesis, cholesterol also serves of linearized targeting vector and subjected to selection with G418
and FIAU. Resistant clones were analyzed by Southern blotting afteras a precursor in steroid hormone synthesis. As might be
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HindIII digestion, using probes 1 and 2 indicated in Figure 1A. Two bile acid excretion (mmol/day per 100 g body weight). After the mice
were weighed, anesthetized, and exsanguinated, the entire smallpositive clones were expanded and injected into C57BL/6 blasto-
cysts to produce five male chimeric mice, which transmitted the intestine and its contents, along with the bulk of the liver and the
gallbladder, were combined and extracted in ethanol with [24-14C]mutant gene through the germline. The mice were genotyped by
Southern blotting of tail DNA after EcoRI digestion. Subsequent taurocholic acid (New England Nuclear) added to correct for proce-
dural losses. The total bile acid content of the extract was quanti-experimental procedures were performed on the C57BL/6±129Sv
mixed strain descendants (F2 and subsequent generations) and tated by HPLC (M. Schwarz, D. W. Russell, J. M. Dietschy, and
S. D. T., unpublished data). These data, together with the respectiverepeated with the second clone, with the exception of the 90-day
2% cholesterol diet. The mice were maintained on a 12 hr light/12 value for recovery of the internal standard, were used to calculate
bile acid pool size (mmol/100 g body weight) and composition. Irre-hr dark cycle and fed ad libitum a standard, cereal-based mouse/
rat diet (No. 7001, Harlan Teklad) containing 4% (w/w) fat and ap- spective of genotype or diet, taurocholic acid and tauromuricholic
acid accounted for more than 95% of the bile acids in the pool inproximately 0.02% (w/w) cholesterol. Where indicated, this diet was
supplemented with 0.2% or 2% (w/w) cholesterol (ICN). The mice all cases. No attempt was made to resolve what fraction of the
muricholic acid peak corresponded to b, a, and v forms of this bilewere euthanized after a 5 hr fast during the early phase of the light
cycle unless otherwise indicated. All mouse procedures used in this acid.
study were performed in accordance with the Institutional Animal
Care and Research Advisory Committee at the University of Texas
Cell Culture and Cotransfection AssaysSouthwestern Medical Center at Dallas.
Transient transfections in Hepa1-6 mouse liver cells were performed
as described (Willy et al., 1995). Cells were maintained at 5% CO2Northern Blotting
in DMEM supplemented with 10% fetal bovine serum. Receptor
Total RNA was extracted using RNA STAT-60 (Tel-Test, Inc.), and
expression plasmids encoding mouse LXRa or LXRb in CMX vectors
mRNA isolated using oligo(dT)-cellulose columns (Pharmacia Bio-
were cotransfected with a luciferase reporter plasmid (TK-CYP7A-
tech). Equivalent amounts of mRNA from 4±6 mice were pooled,
LXREx3-LUC) containing three tandem copies of the DR-4 sequence
and 4±10 mg subjected to Northern blot analysis as described (Lehr-
(gcttTGGTCActcaAGTTCAagtta) from the rat Cyp7a gene (Chiang
man et al., 1987). Mouse cDNA probes for Lxra and Lxrb (Lehmann and Stroup, 1994). 24(S),25-epoxycholesterol was dissolved in etha-
et al., 1997); cholesterol 7a-hydroxylase (Ishibashi et al., 1996); oxy-
nol and added to cells after transfection in medium containing 5%
sterol 7a-hydroxylase (Schwarz et al., 1997); PPARa, PPARd, PPARg
cabosil-treated newborn calf serum. All transfections were normal-
(Kliewer et al., 1994); and 15 other lipid regulatory genes (Shimano
ized to a b-galactosidase internal standard as a control. Data are
et al., 1997) were prepared as described. Sr-B1 cDNA probe was a
presented as mean relative light units (RLUs) from triplicate assays 6
gift from Dr. Helen Hobbs. Probes for SCAP and sterol carrier protein
SEM.
were prepared by RT-PCR with mouse liver poly(A)1 RNA as de-
scribed previously for other probes (Shimano et al., 1996). PCR
primers used were: SCAP, 59-TTAAGCTTTGTCCCGGGCATTCCAA Statistical Analyses
CTGG-39 and 59-TTGAATTCGACTTGGTGAGCACCAACACAT-39; and Values are expressed as mean 6 standard error of the mean (SEM).
sterol carrier protein, 59-AAGAAGCTTGAAGAGGAAGGGGAA-39 and The significance of differences between mean values were evalu-
59-AGCTTAGCTTTGTCCGGCTGAAG-39 (Mori et al., 1991). North- ated using the unpaired Student's t-test. Sample groups showing
erns were quantitated using a phosphorimager (Molecular Dynam- heterogeneity of variance were appropriately transformed before
ics) and standardized against b-actin controls. analysis.
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